DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1 by Fehrenbacher, Jill C. et al.
DNA damage mediates changes in neuronal sensitivity induced by the inflammatory 
mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of 
APE1  
Jill C. Fehrenbachera,b *,1, Chunlu Guoa, Mark R. Kelleya,c, Michael R. Vaskoa,b 
a Indiana University School of Medicine, Department of Pharmacology and Toxicology, U.S.A. 
b Indiana University School of Medicine, Stark Neuroscience Research Institute, U.S.A. 
c Indiana University School of Medicine, Department of Pediatrics, Herman B Wells Center for 
Pediatric Research, U.S.A. 
* Corresponding author. 
Email addresses:  jfehrenb@iu.edu (J.C. Fehrenbacher) 
cguo@iupui.edu (C. Guo) 
mkelley@iu.edu (M. R. Kelley) 
vaskom@iupui.edu (M. R. Vasko) 
1 Postal address: Indiana University School of Medicine, Department of Pharmacology and 
Toxicology, 635 Barnhill Drive, MSA401, Indianapolis, IN 46202, U.S.A. 
DISCLOSURE OF POTENTIAL CONFLICT OF INTEREST: Mark R. Kelley has licensed 
APX3330 through Indiana University Research and Technology Corporation to Apexian 
Pharmaceuticals LLC. Apexian Pharmaceuticals had neither control nor oversight of the studies, 
interpretation, or presentation of the data in this manuscript. 
___________________________________________________________________
This is the author's manuscript of the article published in final edited form as:
Fehrenbacher, J. C., Guo, C., Kelley, M. R., & Vasko, M. R. (2017). DNA damage mediates changes in neuronal 
sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA 
repair function of APE1. Neuroscience. https://doi.org/10.1016/j.neuroscience.2017.09.039
  
2 
 
Abstract 
 
Although inflammation-induced peripheral sensitization oftentimes resolves as an injury heals, 
this sensitization can be pathologically maintained and contribute to chronic inflammatory pain.  
Numerous inflammatory mediators increase the production of reactive oxygen (ROS) and 
nitrogen species (RNS) during inflammation and in animal models of chronic neuropathic pain.  
Our previous studies demonstrate that ROS/RNS and subsequent DNA damage mediate 
changes in neuronal sensitivity induced by anticancer drugs and by ionizing radiation in sensory 
neurons, thus we investigated whether inflammation and inflammatory mediators also could 
cause DNA damage in sensory neurons and whether that DNA damage alters neuronal 
sensitivity.  DNA damage was assessed by pH2A.X expression and the release of the 
neuropeptide, calcitonin gene-related peptide (CGRP), was measured as an index of neuronal 
sensitivity. Peripheral inflammation or exposure of cultured sensory neurons to the inflammatory 
mediators, LPS and MCP-1, elicited DNA damage.  Moreover, exposure of sensory neuronal 
cultures to LPS or MCP-1 resulted in changes in the stimulated release of CGRP, without 
altering resting release or CGRP content.  Genetically enhancing the expression of the DNA 
repair enzyme, apurinic/apyrimidinic endonuclease (APE1) or treatment with a small-molecule 
modulator of APE1 DNA repair activity, both which enhance DNA repair, attenuated DNA 
damage and the changes in neuronal sensitivity elicited by LPS or MCP-1. In conclusion, our 
studies demonstrate that inflammation or exposure to inflammatory mediators elicits DNA 
damage in sensory neurons. By enhancing DNA repair, we demonstrate that this DNA damage 
mediates the alteration of neuronal function induced by inflammatory mediators in peptidergic 
sensory neurons. 
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CC chemokine ligand 2; MPL, methylpyrrolidone; RNS, reactive nitrogen species; ROS, reactive 
oxygen species; TLR4, toll-like receptor 4; TRPV1, Transient Receptor Potential Vanilloid 1  
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Introduction 
Inflammatory mediators that are released from injured tissue and immune cells during damage 
can have acute and chronic effects on the sensitivity of nociceptive primary sensory neurons. 
Prostaglandins, bradykinin, serotonin, tryptases, cytokines, ATP, and other mediators can alter 
the sensitivity of these neurons to various stimuli through posttranslational modifications of 
proteins that contribute to the excitability of sensory neurons (see Richardson and Vasko, 
2002).  Numerous inflammatory mediators also increase the production of reactive oxygen 
(ROS) and nitrogen species (RNS) during inflammation and in animal models of chronic 
neuropathic pain, which can alter excitability of sensory neurons (Bauerova and Bezek, 1999, 
Babior, 2000, Kim et al., 2004, Wang et al., 2004, Remans et al., 2005, Fidanboylu et al., 2011, 
Salvemini et al., 2011). Furthermore, several studies demonstrate that antioxidants can reverse 
changes in neuronal sensitivity (Khattab, 2006, Keeble et al., 2009, Fidanboylu et al., 2011, 
Duggett et al., 2016). The mechanisms by which ROS and RNS alter the sensitivity of sensory 
neurons remain to be determined.    
 
One important consequence of ROS/RNS production in sensory neurons is oxidative DNA 
damage.  The repair of DNA damage is critical to maintain neuronal homeostasis (Brooks, 2002, 
McMurray, 2005, Fishel et al., 2007a, Hetman et al., 2010) and neurons contain multiple repair 
pathways including base excision repair (BER), nucleotide excision repair (NER), mismatch 
repair (MMR), direct damage repair (DDR), and nonhomologous end-joining (NHEJ) or 
homologous recombination (HR), however BER is the predominant neuronal DNA repair 
pathway (Fishel et al., 2007b, Barzilai et al., 2008, Fortini and Dogliotti, 2010).  The BER 
pathway repairs DNA damage in the nucleus and mitochondria, caused by oxidative damage to 
bases as well as alkylation of bases and is likely an important repair pathway for protecting 
neurons.  A major step in the BER pathway involves the enzyme, apurinic/apyrimidinic 
endonuclease/redox effector factor (APE1), which hydrolyzes the phosphodiester backbone 
immediately 5’ to an apurinic/apyrimidinic (AP) site.  This generates a normal 3’-hydroxyl group 
and an abasic deoxyribose-5-phosphate, which is processed by subsequent enzymes of the 
BER pathway. As such, compromising the repair activity of APE1 likely augments oxidative DNA 
damage, whereas enhancing APE1 repair activity could diminish damage.  Indeed, our previous 
studies demonstrate that ROS/RNS and subsequent DNA damage mediate changes in 
neuronal sensitivity induced by anticancer drugs and by ionizing radiation in sensory neurons 
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and that increasing APE1 expression reverses the changes in sensitivity of peptidergic sensory 
neurons (Jiang et al., 2008, Vasko et al., 2011, Kelley et al., 2014).  
 
Because oxidative stress can produce DNA damage in sensory neurons, we determined 
whether inflammation and inflammatory mediators cause DNA damage in sensory neurons.  We 
also examined whether persistent changes in the sensitivity of sensory neurons secondary to 
exposure to inflammatory mediators are reversed by enhancing the DNA BER pathway.  We 
demonstrate that peripheral inflammation induces DNA damage in the soma of neurons of the 
lumbar DRG and recapitulate this DNA damage in DRG cultures exposed to the inflammatory 
mediators, LPS or MCP-1. We also establish that DNA damage mediates changes in neuronal 
sensitivity, as determined by capsaicin-stimulated neuropeptide release by exogenously 
enhancing DNA repair via the overexpression of the enzyme APE1 and use of a small molecule 
APE1 DNA repair enhancer, E3330 (Vasko et al., 2011, Kelley et al., 2014, Georgiadis et al., 
2016, Kelley et al., 2016).  These data identify a novel pathway by which inflammatory 
mediators sustain changes in neuronal sensitivity and highlight the enhancement of neuronal 
DNA repair as a pharmacological target to alleviate inflammatory or chronic pain.  
 
Experimental Procedures 
Materials 
Unless otherwise indicated, tissue culture supplies were purchased from Thermo Fisher 
Scientific (Waltham, MA). Poly-D-lysine, laminin, mouse monoclonal anti-vinculin antibody, 1-
methyl-2-pyrrolidone (MPL), complete Freund’s adjuvant (CFA), Lipopolysaccharides (LPS) 
from Escherichia coli 0111:B4, RS 504393, and routine chemicals were purchased from Sigma-
Aldrich (St. Louis, MO). Nerve growth factor was purchased from Envigo (Indianapolis, IN), 
Normocin and LPS-RS were obtained from InvivoGen (San Diego, CA), and Neuroporter was 
purchased from Genlantis (San Diego, CA). Mouse monoclonal antihuman APE1 antibodies 
were raised in our laboratory and are available from Novus Biologicals (Littleton, CO), mouse 
monoclonal anti-phospho-H2AX antibody was acquired from EMD Millipore (Billerica, MA), and 
anti-Hemagglutinin (HA) antibody conjugated to horseradish peroxidase was purchased from 
Miltenyi Biotec (San Diego, CA).  Chemiluminescence secondary antibodies were acquired from 
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Roche Diagnostics Corp. (Indianapolis, IN). siRNA molecules were purchased from GE 
Dharmicon (Lafayette, CO). 
E3330, also called APX3330, was synthesized per previously published methods (Nyland et al., 
2010), dissolved in N,N-dimethylformamide (Sigma-Aldrich) and stored as a 40mM stock at 
−80°C. LPS was dissolved in MPLand stored as a 50 mM stock at −20°C for a month. 
Recombinant rat CCL2/ MCP-1 protein was purchased from R&D Systems (Minneapolis, MN), 
dissolved in PBS and stored at -20°C for up to a month. The TLR4 antagonist, LPS-RS, was 
dissolved in MPL and stored at −80°C. The CCR2 antagonist, RS 504393, was dissolved in 
MPL and stored at −20°C for a month.  Before drug treatment, the stocks were diluted in F-12 
growth medium and added to cultures and incubated for 2-96 hours as indicated.  
Hindpaw inflammation 
Adult male (150–175 g) Sprague-Dawley rats (Envigo, Indianapolis, IN) were used in all 
experiments. The Animal Care and Use Committee at Indiana University School of Medicine, 
Indianapolis, IN approved all procedures used in these studies. Rats were transiently 
anesthetized with isoflurane and injected subcutaneously with 150 µl of a 1:1 (v/v) solution of 
complete Freund’s adjuvant (CFA) and 0.9% saline into the plantar surface of the right hind 
paw. The induction of inflammation was confirmed by redness and swelling; only animals with 
an increase in the injected paw thickness of 3.5 mm or greater were used in experiments. 
Cell culture 
Dorsal root ganglia (DRG) were dissected from all spinal levels of adult male (150–175 g) 
Sprague-Dawley rats (Envigo, Indianapolis, IN) and the cells were dissociated as previously 
described (Kelley et al., 2014). Briefly, rats were euthanized by CO2 asphyxiation and DRGs 
were collected, trimmed, and then transferred into collagenase solution (1 mg/ml) for incubation 
at 37°C for 1 hr. The digested DRGs were rinsed with growth medium, centrifuged and 
dissociated by mechanical agitation. The cells (~30,000/ well) were plated into each well of 12-
well culture plates precoated with poly-D-lysine and laminin. Cells were maintained in F-12 
media supplemented with 10% horse serum, 2 mM glutamine, 100 µg/ml Normocin, 50 µg/ml 
penicillin, 50 µg/ml streptomycin, 50 µM 5-fluoro-2′-deoxyuridine, 150 µM uridine, and 30 ng/ml 
of NGF in 3% CO2 at 37°C. Growth medium was changed every other day. 
Modulation of APE1 expression 
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As described previously, small interfering RNA to APE1 (APE1siRNA) and a scrambled siRNA 
(SCsiRNA) control were used to decrease APE1 protein expression in sensory neuronal cell 
cultures (Vasko et al., 2005, Jiang et al., 2008). On day 3 in culture, the growth media was 
replaced with 0.5 ml of Opti-MEM 1 media containing 100 nM of APE1siRNA (5′-
GUCUGGUAAGACUGGAGUACC-3′) or SCsiRNA (5′-CCAUGAGGUCAGCAUGGUCUG-3′; 
and 10 µl of the transfection reagent, Neuroporter. On the next day, 0.5 ml of the growth media 
without antibiotics was added to each well. The next day, the siRNA-containing media was 
replaced with normal growth media.  
Lentiviral constructs containing (1) the CMV promoter, HA-tagged APE1, IRES, and enhanced 
green fluorescent protein (EGFP); or (2) CMV, IRES, and EGFP were used to enhance APE1 
protein expression in neuronal cell cultures, as previously described (Vasko et al., 2011). On 
day 5 in culture, 150 pfu/cell of the lentivirus was added to the growth media. Two days later, 
the virus was removed and the cells were grown for an additional 5 days in normal growth 
media. In these studies, we selectively reduced APE1 expression in the cultures with siRNA 
designed against rat APE1 mRNA and added back human APE1 transgenes that were not 
recognized by the rat siRNA, since the human APE1 homolog has a different nucleic acid 
sequence at the siRNA binding site (Vasko et al., 2005). 
Immunoblotting 
Tissues or cells were harvested, lysed in RIPA buffer (Santa Cruz Biotechnology; Dallas, TX), 
sonicated, and cleared of cellular debris by centrifuging at 4000 RPM for 2 minutes. The protein 
concentration in lysates was quantified using Lowry assay. Protein aliquots were 
electrophoresed in a 12% SDS-polyacrylamide gel, transferred to a PVDF membrane, and 
blocked with Tris-buffered saline containing 0.1% Tween-20 (TBST) and 5% nonfat dry milk for 
1 h at room temperature under gentle agitation. Mouse monoclonal antihuman APE1 antibodies 
(1∶1000), mouse monoclonal anti-phospho H2A.X (pH2A.X) antibodies (1∶1000), mouse 
monoclonal anti-vinculin antibody (1∶1000), and anti-Hemagglutinin (HA) antibody were added 
to the blocking solution and incubated for 2 h at room temperature with gentle agitation. 
Antibody binding was detected following appropriate secondary antibody methods using 
chemiluminescence. The density of the bands was measured using Quantity One software from 
Bio-Rad (Hercules, CA) and data were expressed as density of the protein of interest 
normalized to vinculin. 
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Measurement of calcitonin gene-related peptide release 
To assess the stimulated release of treated neuronal cultures , the cultures were washed once 
with HEPES buffer consisting of (in mM) 25 HEPES, 135 NaCl, 3.5 KCl, 2.5 CaCl2, 1 MgCl2, 3.3 
D-glucose, and 0.1% bovine serum albumin, pH 7.4 and maintained at 37°C. Cultures were then 
incubated for successive 10-min intervals with 0.4 ml of HEPES buffer alone (to assess basal 
release), with buffer containing 30 nM capsaicin (to assess stimulated release), then with buffer 
alone (to assess return to basal release). After each incubation, the buffer was removed and 
immunoreactive calcitonin gene-related peptide (CGRP) in each sample was measured using 
radioimmunoassay, as previously described (Chen et al., 1996). After the release experiment, 
the cells in each well were lysed in 0.4 ml of 0.1 M HCl for 20 min and an aliquot was taken to 
measure total CGRP content in each well. Total content (fmol/well) was calculated by adding 
the total amount of CGRP released in all incubations to the total amount of CGRP measured 
from the lysed cells. The release data is calculated as fmol released/well/10 min and expressed 
as the % of CGRP release normalized to the total CGRP content. 
Statistical analysis 
Data are expressed as the mean ± SEM from at least three repeats of each experiment. 
Differences in pH2A.X expression and CGRP release in DRG cultures were determined using 
one- or two-way analysis of variance (ANOVA) and Dunnett’s post hoc test. Differences in 
pH2A.X expression in DRG tissues were determined using Student t-tests. In all cases, 
significance was established as p < 0.05, comparing treated versus controls.  
 
Results 
Hindpaw inflammation elicits DNA damage in the L4/L5 DRG  
The ability of neurons to repair DNA is critically important in maintaining neuronal homeostasis 
(Brooks, 2002, McMurray, 2005, Fishel et al., 2007a, Hetman et al., 2010).  The question 
remains, however, whether peripheral inflammation produces DNA damage.  To determine 
whether inflammation produces DNA damage within the DRG, CFA (1:1 with saline) was 
injected unilaterally into the plantar hindpaw of the rat to elicit inflammation. The average 
increase in paw thickness in hindpaws injected with saline was 0.99 ± 0.03 mm, whereas the 
increase in hindpaws injected with CFA was 5.51 ± 0.12 mm 5 days following injection (n=7).   
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One, two and five days following injection, the animals were sacrificed and the lumbar DRG 
were collected bilaterally. In this manner, DNA damage and protein expression from tissue 
ipsilateral to the inflammation could be compared to the contralateral control.  As can be seen in 
the graph in Figure 1A, inflammation induced an increase in DNA damage, as indicated by a 
58% increase in the phosphorylation of H2A.X (Rogakou et al., 1998) and this increase was first 
observed at the 5 day timepoint (representative blot illustrated in Figure 1B).  To ascertain 
whether DNA damage occurred within the sensory neuronal soma in the DRG, 
immunohistochemistry was performed. As illustrated in representative images in Figure 1C, 
immunoreactivity for pH2A.X was localized to the nuclei of both neurons and support cells.  
The inflammatory mediators, LPS and MCP-1, enhance DNA damage in a time-dependent 
manner 
To ascertain whether exposing sensory neurons to inflammatory mediators can cause DNA 
damage, we utilized cultures of sensory neurons.   We exposed the cultures to LPS or MCP-1 
and then determined DNA damage, as measured by expression of pH2A.X.  As can be seen in 
Figure 2, exposure of neuronal cultures to LPS (1 μg/ml) resulted in a time-dependent increase 
in the levels of pH2A.X, apparent within 8 h of treatment and peaking at 24 h. In a similar 
manner, exposure to MCP-1 (100 ng/ml) induced pH2A.X expression, with an onset of 4 h and 
peak effects at 24 h (Figure 2). Because the peak effects of the inflammatory mediators on DNA 
damage were observed at 24 hours, all subsequent experiments were performed at that time 
point.  
 
The effects of LPS and MCP-1 to induce DNA damage and alter CGRP release are 
reversed by antagonists of the TLR4 and CCR2 receptors 
To demonstrate inflammatory mediator-induced changes in the sensitivity of neurons within 
DRG cultures, we exposed the cultures to increasing concentrations of each of the inflammatory 
mediators for 24 h and then examined the basal and capsaicin-stimulated release of the 
putative nociceptive neuropeptide, CGRP.  As illustrated in Figures 3A and 3B, exposure to 
30nM capsaicin for 10 min increases CGRP release to approximately 10% of the total content of 
CGRP.  Exposing sensory neurons to a low concentration of LPS (1.0 μg/ml) enhanced the 
capsaicin-stimulated release of CGRP to 14.4 ± 1.2 % of total content. In contrast, treatment 
with higher concentrations of LPS significantly decreased the release of CGRP to 6.3 ± 0.4 % of 
total content in cultures treated with 10.0 μg/ml LPS (Figure 3A).  The effects of MCP-1 were 
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analogous to those of LPS; exposure of cultures to low concentrations of MCP-1 for 24 h 
augmented the release of CGRP to 13.0 ± 0.8 and 15.0 ± 1.0 % of total content in cultures 
treated with 0.3 and 1.0 μg/ml MCP-1, respectively, whereas higher concentrations of MCP-1 
(3.0 - 10.0 μg/ml) decreased CGRP release to 7.1 ± 0.3 % and 6.3 ± 1.0 % of total content, 
respectively (Figure 3B). Exposure to various concentrations of LPS or MCP-1 did not alter the 
basal release of CGRP (data not shown).  Furthermore, the changes in release of CGRP were 
not secondary to an altered content of CGRP in the neurons, as the total content of CGRP was 
similar in cultures treated with vehicle, LPS, and MCP-1 (data not shown). 
Although the cognate receptor pathways that are activated by LPS and MCP-1 are the TLR4 
receptor pathway and the CCR2 receptor pathway, respectively (Charo et al., 1994, Poltorak et 
al., 1998), recent reports suggest that these inflammatory agents can modulate other targets 
(Meseguer et al., 2014). Therefore, we determined whether blocking the activation of the TLR4 
or CCR2, using the TLR4 antagonist, LPS-RS (2 µg/ml), or the CCR2 antagonist, RS 50493 (1 
µM), inhibited the effects of the inflammatory mediators to enhance pH2A.X expression and 
alter capsaicin-stimulated CGRP release. In these experiments, we chose to induce DNA 
damage with both low and high concentrations  of LPS and MCP-1. Recent studies have 
demonstrated that LPS treatment of sensory neurons in culture can upregulate the endogenous 
production of CCL2 (Miller et al., 2015), therefore we also examined whether the CCR2 
antagonist would block the effects of LPS on neuronal DNA damage and neuropeptide release. 
The cultures were treated with the receptor antagonists 1 hr prior to the introduction of the 
inflammatory mediators and maintained in the media throughout the exposure. Both low and 
high concentrations of LPS and MCP-1 induced the expression of pH2A.X. The LPS-induced 
increases in expression were reversed by both the TLR4 antagonist and by the CCR2 
antagonist (Figure 3C). Interestingly, the increases in pH2A.X expression induced by both 
concentrations of MCP-1 were reversed by the CCR2 antagonist (Figure 3D) and the TLR4 
antagonist had a modest effect to attenuate DNA damage elicited by low concentrations of 
MCP-1, but did not affect damage induced by the higher concentration of MCP-1 (Figure 3D).  
The effects of the antagonists to block inflammatory mediator-induced changes in neuropeptide 
release also were examined. As observed previously, 1.0 μg/ml LPS increased the stimulated 
release of CGRP from neuronal cultures by 31.9%, whereas 3.0 μg/ml LPS decreased the 
release by 33.6%. Treatment with either the TLR4 or CCR2 antagonist blocked the changes in 
release induced by LPS (Figure 3E). Exposing neuronal cultures to 0.3 μg/ml MCP-1 for 24 hr 
enhanced CGRP release by 49.1% compared to vehicle control. This augmentation was 
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prevented by treatment with RS 50493 (Figure 3F), but not the TLR4 antagonist. As with higher 
concentrations of LPS, a 3 μg/ml MCP-1 treatment decreased the release of CGRP by 33.1%, a 
decrease that was reversed by the CCR2 antagonist, but unaffected by the TLR4 antagonist 
(Figure 3F). 
 
LPS-induced DNA damage and alteration of CGRP release are reversed by 
overexpression of wildtype APE1 or a repair competent APE1 mutant, but not by an APE1 
repair-deficient transgene. 
We next examined whether enhancing or diminishing the activity of APE1, a critical enzyme in 
the BER pathway, altered the DNA damage and changes in capsaicin-stimulated CGRP release 
induced by LPS and MCP-1 treatment.  For these studies, cultures were treated as illustrated in 
Figure 4A. Cultures were transfected with SCsiRNA or rat APE1siRNA on days 4-6 in culture 
and then exposed to lentivirus containing expression constructs for vector control, human 
wildtype APE1, mutant c65 APE1, or mutant 226/117 APE1 on days 6-8 in culture. The C65 
APE1 mutant has impaired redox, but normal repair function whereas the 226/117 APE1 mutant 
has impaired DNA repair function but normal redox activity (Luo et al., 2008, Vasko et al., 2011). 
In one set of cultures, the neurons were treated with E3330 on days 10-14 days in culture.  
E3330 is a small molecule compound that modulates APE1 activity to enhance DNA repair in 
sensory neurons (Luo et al., 2008, Kelley et al., 2014). Finally, cultures were treated with LPS (3 
µg/ml) for the 24 h immediately prior to experiments.  
When cultures treated with SCsiRNA and viral vector control were exposed to LPS for 24 h, 
there was a significant induction of pH2A.X expression (Figures 4B and 4C). Exogenous 
expression of either wildtype APE1 or C65 APE1 (repair-competent), at levels ~175% of 
wildtype endogenous expression as indicated by the expression of HA tag (Figure 4B), 
ameliorated the ability of LPS to induce DNA damage, decreasing the density of pH2A.X by 
95% and 94%, respectively. In contrast, exogenous expression of the 227/177 APE1 mutant 
(repair-deficient) had no effect on LPS-induced pH2A.X levels.  Similar effects were observed in 
cultures treated with APE1siRNA, which decreased APE1 expression to ~ 20% of wildtype 
expression (Figures 4B and 5B).  Exposure to LPS in cultures treated with APE1siRNA and viral 
vector control increased the expression of pH2A.X and this trended to be more extensive 
compared to the SCsiRNA-treated cultures (Figure 4C).  As in cells exposed to SCsiRNA, 
exogenous expression of either wildtype APE1 or C65 APE1 (repair-competent), attenuated the 
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ability of LPS to induce DNA damage, whereas overexpression of 226/177 APE1 had no effect 
Figures 4B and 4C).   Interestingly, the enhancement of the DNA repair activity of APE1 by 
E3330 mimicked the effects of exogenously expressing wildtype APE1. Pretreatment with 
E3330 (20 μM) reduced the induction of pH2A.X in both SCsiRNA- and APE1siRNA- treated 
cultures (Figure 4C).  
To discover whether a reversal in DNA damage also reversed the effects of LPS on the 
sensitivity of peptidergic neurons, we again examined the capsaicin-stimulated release of 
CGRP.   In a manner analogous to the data illustrated in Figure 3A, LPS (3 µg/ml) treatment 
attenuated the release of CGRP stimulated by capsaicin (Figure 4D). In cultures treated with 
SCsiRNA and a viral vector control, the stimulated release of CGRP from vehicle-treated wells 
was 10.4 ± 0.6 % of total content, whereas release from cells treated with LPS for 24 h was 
decreased to 7.1 ± 0.6 % of total content. Exogenous expression of either wildtype APE1 or C65 
APE1 (repair-competent) reversed the effects of LPS, so that the stimulated release of CGRP 
was 10.4 ± 1.1 and 10.5 ± 0.4 % of total content in the presence of APE1 wildtype and C65 
mutant, respectively. Exogenous expression of the repair-deficient APE1 mutant did not reverse 
the effects of LPS, as release was decreased to 7.0 ± 0.9 % of total content. Finally, treatment 
with E3330 also protected against the effects of LPS on CGRP release; release following E3330 
treatment was 9.7 ± 0.8 % of total content, which was no different from release in the absence 
of LPS treatment. These results support the role of APE1’s DNA repair activity and not it’s redox 
signaling function in preventing LPS-induced changes in neuronal sensitivity. 
 
MCP-1-induced DNA damage and alteration of CGRP release are reversed by 
overexpression of wildtype APE1 or a repair competent APE1 mutant, but not by an APE1 
repair-deficient transgene 
Using the same methods described for experiments with LPS, we manipulated APE1 
expression and activity and then treated cultures with MCP-1 (0.3 µg/ml) for the 24 h 
immediately prior to experiments (Figure 5A).   As observed in non-treated cultures (Figure 2), 
sensory neurons treated with SCsiRNA and a control viral vector then exposed to MCP-1 had 
enhanced expression of pH2A.X (Figures 5B and 5C). Increasing the exogenous expression of 
wildtype or repair-competent APE1 (as indicated by expression of HA) prevented the ability of 
MCP-1 to increase pH2A.X; levels of pH2A.X were decreased to 36.9 and 33.6% of the MCP-1-
induced increase in the presence of wildtype and C65 APE1, respectively. In contrast, 
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exogenous expression of the repair-deficient APE1 (226/177) did not prevent the MCP-1-
induced expression of pH2A.X.  Similar effects were observed in cultures treated with 
APE1siRNA; MCP-1 induced pH2A.X and this trended to be more extensive compared to the 
SCsiRNA-treated cultures (Figures 5B and 5C).  As in cells exposed to SCsiRNA, exogenous 
expression of either wildtype APE1 or C65 APE1 (repair-competent), attenuated the ability of 
MCP-1 to induce DNA damage, whereas overexpression of 226/177 APE1 had no effect 
(Figures 5B and 5C).   As observed with LPS, treatment of sensory neurons exposed to 
SCsiRNA or APE1siRNA with E3330 reduced the induction of pH2A.X by MCP-1 (Figure 5C)   
To determine whether these changes in pH2A.X expression correlated with changes in the 
neuronal sensitivity of peptidergic sensory neurons, we examined the release of CGRP 
stimulated by capsaicin (Figure 5D). Following treatment with SCsiRNA, MCP-1 (0.3 µg/ml) 
enhanced the release of CGRP. This enhancement was not observed when APE1 expression 
was upregulated exogenously with either the wildtype APE1 or a repair-competent/redox 
deficient APE1 (C65 APE1). Exogenous expression of the repair-deficient APE1 (226/177); 
however, did not prevent the MCP-1 induced sensitization of CGRP release (Figure 5D, light 
gray columns). In cultures treated with APE1siRNA, MCP-1 treatment caused a decrease in 
CGRP release, suggesting that the response to MCP-1 is shifted leftwards, based on the 
concentration response curve presented in Figure 3B, in cultures with reduced DNA repair 
activity. This decrease was reversed by exogenous expression of wildtype or repair-competent 
APE1, but unaffected by expression of repair-deficient APE1 (Figure 5D, dark gray columns). As 
observed with the induction of pH2A.X expression, treatment of cultures with E3330 prevented 
the change in CGRP release induced by MCP-1 exposure (Figure 5D).  Collectively, these data 
support the notion that MCP-1 induces DNA damage in neuronal nuclei and that this DNA 
damage mediates changes in neuronal sensitivity. 
 
Discussion 
Our results demonstrate that peripheral inflammation enhances DNA damage, as indicated by 
an increase in pH2A.X expression, within the soma of sensory neurons innervating the inflamed 
tissue.  An increase in pH2A.X expression also is observed in sensory neuronal cultures, 
following exposure to LPS or MCP-1.  In addition to DNA damage, exposure of sensory 
neuronal cultures to LPS or MCP-1 results in changes in the sensitivity of the neurons, as 
indicated by the stimulated release of the neuropeptide, CGRP, without altering resting release 
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or the total content of CGRP.  Genetic manipulation of APE1 expression or treatment with a 
small-molecule modulator of APE1 DNA repair activity, E3330, to enhance DNA repair via the 
BER pathway attenuates DNA damage elicited by LPS or MCP-1. Enhancement of APE1 DNA 
repair activity reverses the inflammatory mediator-induced changes in neuronal sensitivity. 
Additionally, the inhibition of APE1 redox signaling function did not impact the protection of the 
cells from inflammation induced cellular alterations. These data support our previous findings 
demonstrating that it is the DNA repair and not the redox signaling component of APE1 that is 
necessary for protection of sensory neuronal function and extends these findings into 
inflammation-induced alterations of sensory neurons (Jiang et al., 2008, Vasko et al., 2011, 
Kelley et al., 2014).  Of interest, we also demonstrate that DNA damage and changes in 
neuronal sensitivity induced by LPS are inhibited by the CCR2 antagonist, suggesting that long-
term sensitization induced by TLR4 activation might be mediated through an increase in the 
production and putative autocrine activity of CCL2/MCP-1. 
Injection of CFA into the hindpaw of a rat elicits behavioral hypersensitivity to thermal and 
mechanical stimuli (Stein et al., 1988, Woolf et al., 1994), and this hypersensitivity has been 
attributed to the enhancement of local inflammatory mediators within the damaged tissue 
(Ferreira et al., 1988, Williams and Higgs, 1988, Cunha et al., 1992, Ferreira et al., 1993, 
Safieh-Garabedian et al., 1995) or in the soma of the neurons (Jeon et al., 2008). The signaling 
pathways by which inflammation alters the sensitivity of primary afferent neurons have been 
investigated extensively and include posttranslational modifications to reversibly alter the 
function of receptors, ion channels, or associated regulatory proteins and transcriptional 
regulation to alter the expression of proteins that contribute to excitability of sensory neurons 
(Neumann et al., 1996).  In the latter case, DNA damage could alter the expression of various 
proteins and/or induce novel expression of mutated proteins to chronically alter the function of 
sensory neurons. 
Although posttranslational modifications clearly alter the sensitivity of sensory neurons, these 
effects are readily reversible when the evoking stimulus is removed.  In contrast, DNA damage, 
unless repaired can result in permanent alterations in the phenotype of post-mitotic cells.  Thus, 
to identify a causative role for DNA damage in maintaining neuronal sensitization induced by 
inflammation, we utilized neuronal cultures derived from DRG. The cultures were treated with 
the TLR4 or CCR2 ligands, LPS or MCP-1/CCL2, respectively, to mimic the effects of 
inflammation on neurons in culture.  LPS is expressed on the outer membrane of gram negative 
bacteria, including the inactivated Mycobacterium tuberculosis present in complete Freund’s 
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adjuvant used in our in vivo inflammation studies.  LPS is an exogenous ligand for the TLR4 
receptor, which is expressed in sensory neurons (Diogenes et al., 2011, Li et al., 2014, Li et al., 
2015) and exposure to LPS enhances the expression of TNFα, IL-1β, COX-2 and MCP-1 in 
sensory neurons (Tse et al., 2014, Miller et al., 2015), thus recapitulating the activation of 
multiple pathways elicited by inflammation.  Furthermore, LPS acutely enhances the sensitivity 
of sensory neurons as demonstrated by nociceptive behaviors following injection into the 
hindpaw of rodents (Ferreira et al., 1993, Calil et al., 2014) and by in vitro experiments, where 
LPS enhances the excitability and exocytotic activity of sensory neurons (Hou and Wang, 2001, 
Diogenes et al., 2011, Meseguer et al., 2014).   
MCP-1 is a cytokine that is upregulated in DRG by inflammation (Jeon et al., 2008), and 
released from DRG or dorsal spinal cord via stimulation of sensory neurons (Dansereau et al., 
2008).  MCP-1 exposure has been shown to upregulate the neuronal expression of TRPV1 and 
NaV1.8 (Kao et al., 2012), potentially mediated by the activation of NFκB (Tse et al., 2014, Zhao 
et al., 2014).  MCP-1 also enhances the sensitivity of sensory neurons as evidenced by an 
increase in nociceptive behaviors following hindpaw injection (Dansereau et al., 2008) and by a 
direct stimulation of CGRP release from cultures derived from neonatal DRG (Qin et al., 2005b).  
MCP-1 is a ligand for the CCR2 receptor. Although the CCR2 is not expressed in DRG neurons 
derived from naïve animals, the CCR2 is expressed in DRG following inflammation or nerve 
injury (White et al., 2005, Miller et al., 2012, Zhang et al., 2013). Furthermore, the CCR2 is 
functionally active in cultures derived from DRG (Qin et al., 2005b, Kao et al., 2012).  
It is appreciated that inflammation and the inflammatory mediators, LPS and MCP-1 acutely 
activate signaling pathways that contribute to hypersensitivity, which are likely independent of 
DNA damage. Indeed, changes in neuronal excitability induced by exogenous administration of 
LPS and MCP-1 can be observed at timepoints prior to the development of DNA damage (<2 
hrs, Figure 2) (Hou and Wang, 2001, Qin et al., 2005b, Diogenes et al., 2011, Meseguer et al., 
2014).  In addition to the acute sensitization of neurons, inflammatory mediators also can 
enhance the generation of ROS/RNS via enzymatic (NADPH oxidase) and autooxidation 
reactions (metabolism-induced increases in electron transport chain leakage) (Bauerova and 
Bezek, 1999, Babior, 2000, Qin et al., 2005a, Remans et al., 2005, Ibi et al., 2008, Hackel et al., 
2013). Because we found that the effects of LPS could be attenuated by a CCR2 antagonist, we 
suspect that the maintenance of hypersensitivity induced by LPS is mediated through activation 
of TLR4 and subsequent upregulation of MCP-1/CCL2.  This finding was intriguing because 
activation of TLR4 elicits the generation of ROS/RNS in macrophages (Qin et al., 2005a, Zhang 
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et al., 2015), yet in neurons TLR4 activation cannot maintain sensitivity without activation of the 
CCR2. Therefore, we propose that the quantitative, spatial and temporal aspects of ROS/RNS 
generation are critical for inducing DNA damage and will be studied further. Two recent 
publications suggest that NADPH oxidase plays a large role in modulating the sensitivity of 
sensory neurons in the context of inflammation (Ibi et al., 2008, Ding et al., 2016).   
ROS/RNS function as agonists for the TRPV1 and TRPA1 channels (Andersson et al., 2008, 
Sawada et al., 2008, Keeble et al., 2009, Ito et al., 2013, Lin et al., 2015). In addition to the 
acute effects of ROS to enhance TRPV1 and TRPA1 sensitivity, an intracellular increase in free 
radical moieties can lead to the oxidation of molecules, including nucleic acids, proteins, and 
lipids, leading to potentially serious consequences for sensory neurons. One potential long-term 
consequence of this oxidative stress is oxidative DNA damage.  Although sensory neurons have 
endogenous antioxidant mechanisms and DNA repair pathways to combat excessive production 
of ROS/RNS, excessive oxidative stress can overwhelm the endogenous antioxidants and DNA 
repair mechanisms.  Although sensory neurons are post-mitotic, DNA damage can still have 
critical consequences on the integrity of gene transcription and for the maintenance of neuronal 
homeostasis (Fishel et al., 2007b).  Indeed, we recently demonstrated that DNA damage was a 
causative factor in altering the sensitivity of neurons following treatment with chemotherapies 
that cause oxidative DNA damage (Vasko et al., 2005, Jiang et al., 2008, Jiang et al., 2009, 
Kelley et al., 2014). Our studies identified that changes in neuronal sensitivity could be reversed 
by repair of oxidative lesions induced by cisplatin or ionizing radiation, suggesting an important 
role for ROS/RNS in modulating neuronal sensitivity by damaging DNA.    
Inflammation-induced DNA damage in sensory ganglia are not restricted to the sensory 
neurons. There is abundant evidence to support inflammation- or inflammatory mediator-
induced activation of satellite glial cells, as evidenced by an increase in the expression of glial 
fibrillary acid protein (GFAP) and phosphorylation of ERK (Villa et al., 2010, Matsuura et al., 
2013, Blum et al., 2014, Lukacs et al., 2015). Mechanistic studies have identified putative 
signaling pathways by which the activation of satellite cells enhances the excitability or 
sensitivity of sensory neurons and these include: coupling between the glial and neuronal cells 
via gap junctions (Dublin and Hanani, 2007) and enhanced release of cytokines, PGE2 and 
glutamate from the glial cells (Takeda et al., 2008, Capuano et al., 2009, Rozanski et al., 2013). 
In our experiments, we did not distinguish whether alteration in DNA damage or repair was 
limited to sensory neurons.  It is likely that inflammation-induced DNA damage also is present 
within the satellite glial cells and it is conceivable that this contributes to the sustained 
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hypersensitivity of neurons.  Consequently, further experiments are warranted to examine this 
possibility. 
 
Our current findings demonstrating that DNA damage is critical for the maintenance of changes 
in peptidergic neuronal function induced by inflammation expand on our previous studies with 
anticancer drugs (Jiang et al., 2008, Kelley et al., 2014, Kelley and Fehrenbacher, 2017).  
Reducing the expression of APE1 increases the neurotoxicity produced by LPS and MCP-1 
exposure, whereas augmenting the DNA repair activity of APE1, whether through enhanced 
expression or with E3330, lessened the neurotoxicity. In addition to the AP endonuclease 
function of APE1, the enzyme also functions as a protein-protein redox signaling molecule 
modulating the redox status of transcription factors to regulate their function (Fishel and Kelley, 
2007, Luo et al., 2008, Jiang et al., 2010, Fishel et al., 2011, Kelley et al., 2012).  Our findings 
that overexpression of the DNA repair-competent APE1, but not the redox-competent APE1, 
suggest that the DNA repair component of APE1 is essential to reverse sensitization induced by 
inflammatory mediators. These results parallel our earlier findings, that the neuroprotective 
effect of APE1 to prevent cisplatin-induced toxicity required its DNA repair function, but not its 
redox signaling function (Jiang et al., 2008, Vasko et al., 2011). The implication, therefore, is 
that exposure of sensory neurons to inflammation can elicit hypersensitivity through a variety of 
signaling pathways; however, the maintenance of this sensitization is dependent on DNA 
damage and this damage is the crux of the problem.  
 
What is still unclear is how seemingly random DNA damage elicited by inflammation or 
inflammatory mediators can elicit such a reproducible phenotype to sustain neuronal 
hypersensitivity.  The major oxidative DNA lesion formed by oxidative stress, 8oxoG, has been 
suspected to contribute to the development of inflammation and aging (Shigenaga et al., 1994, 
David et al., 2007). Further experiments examining the role of OGG1 in neuronal function are 
ongoing to discern how 8oxoG affects sensory neurons.  The redox function of APE1 already 
has been recognized as contributing to an inflammatory response in other cell types (Jedinak et 
al., 2011), but our findings are the first to implicate a protective role for the DNA repair function 
of APE1 and not the redox function. We hypothesize that posttranslational and transcriptional 
effects of inflammatory mediators can mediate the induction of hypersensitivity in neurons, but 
DNA damage maintains these changes due to the impact of oxidative DNA lesions on 
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transcriptional activity. Thus, inflammation could cause functional changes in neurons that are 
reproducible and that enhanced DNA repair could reverse the functional changes in neurons 
induced by the damage. Oxidative damage to DNA is known to alter the ability of transcription 
factors to recognize and bind promoter regions (Ziel et al., 2004, Gillespie et al., 2009, Pastukh 
et al., 2015), thus the DNA damage induced by inflammation might be reproducible because of 
damage to specific promoter/repressor regions of genes or transcription factors that are already 
activated by inflammation (Ruchko et al., 2009). Oxidative DNA damage, and specifically 
8oxoG, has surfaced as a significant signaling mechanism for gene activation in promoter 
regions (Fleming et al., 2017). 
In conclusion, our studies demonstrate that inflammation or exposure to inflammatory mediators 
elicits DNA damage in sensory neurons. By enhancing BER, we demonstrate that this DNA 
damage mediates the maintenance of neuronal hypersensitivity induced by inflammatory 
mediators. Although we have established that DNA damage is critical for the maintenance of 
changes in neuronal sensitivity, the specific pathways by which inflammatory mediators 
generate DNA damage, the specific types of DNA damage, and how DNA damage results in 
reproducible changes in neuronal sensitivity are still unknown and will be explored in future 
studies.  
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Figure Legends 
 
Figure 1. DNA damage is enhanced in the lumbar DRG following hindpaw inflammation. A. 
Representative western blot of pH2A.X and vinculin (loading control) expression in contralateral 
and ipsilateral L4/L5 DRG 5 days following unilateral CFA injection into the rat hindpaw. B. Each 
column represents the mean ± SEM of the density of pH2A.X from 6 experiments normalized to 
the amount of vinculin. An asterisk indicates a statistically significant increase in the DRG 
ipsilateral to CFA injection compared to those contralateral to the injection using Student t-test. 
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C. Photomicrographs (20X) of pH2A.X in L5 DRG from a rat 5 days after CFA injection. Green 
fluorescence indicates the immunoreactivity to pH2A.X. 
 
Figure 2. DNA damage is enhanced in neuronal cultures in a time-dependent manner following 
exposure to inflammatory mediators. A. Representative western blots for pH2A.X and vinculin 
(loading control) from cultures grown in the absence or presence of LPS or MCP-1 for the 
indicated time periods. B. Each column represents the mean ± SEM of pH2A.X band density 
from 3 experiments normalized to that of vinculin following treatment with 1 μg/ml LPS (light 
bars) or 100 ng/ml MCP-1 (dark bars). An asterisk indicates a significant difference from 
expression at time zero using one-way ANOVA with Dunnett’s post-test.  
 
Figure 3. CGRP release from neuronal cultures is altered following exposure to inflammatory 
mediators and the changes in DNA damage or stimulated CGRP release following exposure to 
LPS or MCP-1 are reversed by antagonists to the TLR4 (LPS) and CCR2 (MCP-1 and LPS). A-
B. Columns represent the mean ± SEM of CGRP release stimulated by a 10-minute exposure to 
30 nM capsaicin following a 24 hr exposure to increasing concentrations of LPS (A) or MCP-1 
(B). An asterisk indicates a significant difference from release in the absence of LPS or MCP-1 
using one-way ANOVA with Dunnett’s post-test. C-D. Columns represent the mean ± SEM of 
the density of pH2A.X from 3-4 experiments normalized to the amount of vinculin following a 
24hr exposure to LPS (C) or MCP-1 (D) in the absence or presence of LPS-RS or RS 50493, as 
indicated. E-F. Columns represent the mean ± SEM of CGRP release stimulated by a 10-minute 
exposure to 30 nM capsaicin following a 24hr exposure to LPS (E) or MCP-1 (F) in the absence 
or presence of LPS-RS or RS 50493, as indicated. An asterisk indicates a significant difference 
from expression/ release in the presence of vehicle treatment in the absence of antagonists, 
whereas a cross indicates a significant difference from expression/ release in the presence of 
inflammatory mediator treatment compared to inflammatory mediator ± antagonist using two-
way ANOVA with Dunnett’s post-test.   
 
Figure 4. The effects of LPS to induce DNA damage and inhibit CGRP release are reversed by 
increasing APE1-mediated DNA repair. A. Treatment schema. B. Representative western blots 
for pH2A.X, APE1, HA tag, and vinculin (loading control) from cultures grown in the absence or 
presence of LPS for 24hr following the indicated pretreatments. C. Each column represents the 
mean ± SEM of pH2A.X band density from 3 experiments normalized to vinculin induced by 
treatment with 3 μg/ml LPS following the indicated pretreatments in conjunction with SCsiRNA 
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(light bars) or APE1siRNA (dark bars). An asterisk indicates a significant difference from 
expression compared to SCsiRNA-treated vector control using two-way ANOVA with Dunnett’s 
multiple comparisons post-test.  D. Each column represents the mean ± SEM of CGRP release 
(expressed as % of total content) stimulated by capsaicin following treatment with 3 μg/ml LPS 
in the absence and presence of APE1 overexpression, as indicated, in conjunction with 
SCsiRNA (light bars) or APE1siRNA (dark bars). An asterisk indicates a significant difference 
from release in the absence of LPS using two-way ANOVA with Dunnett’s multiple comparisons 
post-test.  
 
Figure 5. The effects of MCP-1 to induce DNA damage and augment CGRP release are 
reversed by increasing APE1-mediated DNA repair. A. Treatment schema. B. Representative 
western blots for pH2A.X, APE1, HA tag, and vinculin (loading control) from cultures grown in 
the absence or presence of MCP-1 for 24hr following the indicated pretreatments. C. Each 
column represents the mean ± SEM of pH2A.X band density from 4 experiments normalized to 
vinculin induced by treatment with 0.3 μg/ml MCP-1 following the indicated pretreatments in 
conjunction with SCsiRNA (light bars) or APE1siRNA (dark bars). An asterisk indicates a 
significant difference from expression compared to SCsiRNA-treated vector control using two-
way ANOVA with Dunnett’s multiple comparisons post-test.  D. Each column represents the 
mean ± SEM of CGRP release (expressed as % of total content) stimulated by capsaicin 
following treatment with 0.3 μg/ml MCP-1 in the absence and presence of APE1 
overexpression, as indicated, in conjunction with SCsiRNA (light bars) or APE1siRNA (dark 
bars). An asterisk indicates a significant difference from release in the absence of MCP-1 using 
two-way ANOVA with Dunnett’s multiple comparisons post-test.  
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Highlights 
 
 Peripheral inflammation or exposure of sensory neurons to the inflammatory mediators, 
LPS and MCP-1, elicits DNA damage 
 Exposure of sensory neuronal cultures to LPS or MCP-1 results in changes in the 
stimulated release of CGRP 
 Genetically enhancing APE1 expression or treatment with the small molecule, E3330, 
increases DNA repair 
 An increase in DNA repair attenuates DNA damage and the changes in neuronal 
sensitivity elicited by LPS or MCP-1 
 
 
